GEN Exclusives

More »

October 15, Vol. 28, No. 18

  • Columns

    • VC Funding for Biotech Firms
    • J. Leslie Glick
    • As I write this column, we are now experiencing the biggest financial crisis since the stock market crash of 1929 and the Great Depression Eventually this crisis will be resolved, and life and business will go on... more »
    • What's Driving Dealmaking in Biopharma?
    • In the Wall Street Biobeat column of the September 1 issue of GEN, Robert Dellenbach wrote that significant changes in the global economy and venture capital activity have dramatically impacted the life sciences industry Moreover, his article appeared even before ... more »
    • Animal Therapeutics and Diagnostics
    • Melissa Elder
    • The animal body is similar to the human body in terms of structure and functioning parts, thus providing an incredible need for safe and effective treatments Many of the products offered to the human pharmaceutical and device industry are identical ... more »
    • Engineering Droplets for DNA Sequencing
    • Carol Potera
    • Scientists once performed experiments in test tubes, then reduced the size of reaction volumes to fit into wells in microtiter plates Now, RainDance Technologies plans to miniaturize reactions even more by restricting assays to uniform microscopic droplets in emulsions... more »
    • Taking DNA-Guided Medicine to the Clinic
    • A recent review in the Journal of the American Medical Association concluded that genomic medicine should be part of the risk assessment and treatment of common chronic diseases, yet knowledge about genomic medicine is not being integrated into clinical practice... more »
    • Advanced Imaging Applications
    • Richard A. Stein
    • Advanced imaging has found important applications in many facets of drug discovery In a revolutionary approach, Scott Malstrom, PhD, former head of in vivo imaging at Ore Pharmaceuticals, describes the use of in vivo biophotonic imaging to explore an ACE2 ... more »